These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 16158255)
1. Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells. Tokar EJ; Webber MM Clin Exp Metastasis; 2005; 22(3):275-84. PubMed ID: 16158255 [TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells. Tokar EJ; Webber MM Clin Exp Metastasis; 2005; 22(3):265-73. PubMed ID: 16158254 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells. Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637 [TBL] [Abstract][Full Text] [Related]
4. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Skowronski RJ; Peehl DM; Feldman D Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D. Flanagan JN; Young MV; Persons KS; Wang L; Mathieu JS; Whitlatch LW; Holick MF; Chen TC Anticancer Res; 2006; 26(4A):2567-72. PubMed ID: 16886665 [TBL] [Abstract][Full Text] [Related]
6. Cholecalciferol (vitamin D3) and the retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) are synergistic for chemoprevention of prostate cancer. Tokar EJ; Ancrile BB; Ablin RJ; Webber MM J Exp Ther Oncol; 2006; 5(4):323-33. PubMed ID: 17024972 [TBL] [Abstract][Full Text] [Related]
7. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Schwartz GG; Wang MH; Zang M; Singh RK; Siegal GP Cancer Epidemiol Biomarkers Prev; 1997 Sep; 6(9):727-32. PubMed ID: 9298581 [TBL] [Abstract][Full Text] [Related]
8. The role of Vitamin D3 metabolism in prostate cancer. Lou YR; Qiao S; Talonpoika R; Syvälä H; Tuohimaa P J Steroid Biochem Mol Biol; 2004 Nov; 92(4):317-25. PubMed ID: 15663995 [TBL] [Abstract][Full Text] [Related]
9. Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. Swami S; Krishnan AV; Wang JY; Jensen K; Horst R; Albertelli MA; Feldman D Endocrinology; 2012 Jun; 153(6):2576-87. PubMed ID: 22454149 [TBL] [Abstract][Full Text] [Related]
10. Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. Rashid SF; Moore JS; Walker E; Driver PM; Engel J; Edwards CE; Brown G; Uskokovic MR; Campbell MJ Oncogene; 2001 Apr; 20(15):1860-72. PubMed ID: 11313934 [TBL] [Abstract][Full Text] [Related]
11. Regulation of human vitamin D(3) 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells. Ellfolk M; Norlin M; Gyllensten K; Wikvall K Mol Pharmacol; 2009 Jun; 75(6):1392-9. PubMed ID: 19286836 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE. Sepulveda VA; Weigel NL; Falzon M Steroids; 2006 Feb; 71(2):102-15. PubMed ID: 16243370 [TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. Kim S; Shevde NK; Pike JW J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825 [TBL] [Abstract][Full Text] [Related]
14. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. Hedlund TE; Moffatt KA; Miller GJ Endocrinology; 1996 May; 137(5):1554-61. PubMed ID: 8612485 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Miller GJ; Stapleton GE; Hedlund TE; Moffat KA Clin Cancer Res; 1995 Sep; 1(9):997-1003. PubMed ID: 9816072 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators. Inaba Y; Yamamoto K; Yoshimoto N; Matsunawa M; Uno S; Yamada S; Makishima M Mol Pharmacol; 2007 May; 71(5):1298-311. PubMed ID: 17325131 [TBL] [Abstract][Full Text] [Related]
17. [The influence of isoflavonoids on the antitumor activity of vitamin D3]. Wietrzyk J Postepy Hig Med Dosw (Online); 2007; 61():253-60. PubMed ID: 17507873 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of the anti-proliferative action of 25-hydroxy-19-nor-vitamin D(3) in human prostate cells. Munetsuna E; Nakabayashi S; Kawanami R; Yasuda K; Ohta M; Arai MA; Kittaka A; Chen TC; Kamakura M; Ikushiro S; Sakaki T J Mol Endocrinol; 2011 Oct; 47(2):209-18. PubMed ID: 21693624 [TBL] [Abstract][Full Text] [Related]
19. Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma. Bergadà L; Pallares J; Maria Vittoria A; Cardus A; Santacana M; Valls J; Cao G; Fernàndez E; Dolcet X; Dusso AS; Matias-Guiu X Lab Invest; 2014 Jun; 94(6):608-22. PubMed ID: 24732451 [TBL] [Abstract][Full Text] [Related]
20. Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model. Giangreco AA; Dambal S; Wagner D; Van der Kwast T; Vieth R; Prins GS; Nonn L J Steroid Biochem Mol Biol; 2015 Apr; 148():156-65. PubMed ID: 25305352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]